Researchers at Washington University in St. Louis have made significant strides in the fight against neurodegenerative diseases such as ALS and Parkinson's.
Led by Meredith Jackrel, an associate professor of chemistry, the team has developed a novel method for engineering enzymes that could potentially lead to new therapeutic options.
This advancement, published on June 13, 2026, may open doors for future research aimed at addressing these challenging medical conditions.